Skip to main content
OpenTrials

Clinical trial condition

Immunoproliferative Disorders

Explore clinical trials studying Immunoproliferative Disorders. Study availability and eligibility vary by location and protocol.

10,013 public trials 2,032 recruiting studies
Refine in advanced search Browse all conditions

Immunoproliferative Disorders trial results

Completed

Study of Nivolumab in Subjects With Relapsed or Refractory Follicular Lymphoma (FL) (CheckMate 140)

NCT02038946

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • Mayo Clinic Arizona Phoenix, Arizona, United States
  • Division Of Hematology & Oncology Ctr. For Health Sciences Los Angeles, California, United States
  • Winship Cancer Institute. Atlanta, Georgia, United States
  • Beth Israel Deaconess Medical Center (BIDMC) Boston, Massachusetts, United States
View all 45 locations
View Trial Details
Completed

Preventing Anthracycline Cardiovascular Toxicity With Statins (PREVENT)

NCT01988571

Conditions
Breast Cancer, Breast Diseases, Breast Neoplasms, +11 more
Locations
  • Kaiser Permanente Los Angeles Medical Center Los Angeles, California, United States
  • MedStar Georgetown University Hospital Washington D.C., District of Columbia, United States
  • MedStar Washington Hospital Center Washington D.C., District of Columbia, United States
  • Northwestern University Chicago, Illinois, United States
View all 51 locations
View Trial Details
Completed

A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting

NCT03720561

Conditions
Chronic Disease, Disease Attributes, Hematologic Diseases, +13 more
Locations
  • Ospedali Riuniti Di Ancona Ancona, Italy
  • U.O.C. Ematologia e Terapia Cellulare Ospedale C e G Mazzoni Ascoli Piceno, Italy
  • U.O. Ematologia con Trapianto- AOU Policlinico di Bari Bari, Italy
  • U.O. Ematologia Istituto Tumori Giovanni Paolo II Bari, Italy
View all 39 locations
View Trial Details
Completed

Ofatumumab With IVAC Salvage Chemotherapy in Diffuse Large B Cell Lymphoma Patients

NCT01481272

Conditions
Diffuse Large B Cell Lymphoma, Hemic and Lymphatic Diseases, Immune System Diseases, +9 more
Locations
  • Dolnośląskie Centrum Transplantacji Komórkowych Wroclaw, Lower Silesian Voivodeship, Poland
  • Instytut Hematologii i Transfuzjologii Warsaw, Masovian Voivodeship, Poland
  • Centrum Onkologii - Istytut im. M.Sklodowskiej-Curie Warsaw, Masovian Voivodeship, Poland
  • Szpital Specjalistyczny w Brzozowie Podkarpacki Ośrodek Onkologiczny im. ks. Bronisława Markiewicza Brzozów, Podkarpackie Voivodeship, Poland
View Trial Details
Completed

A Study of Nivolumab in Relapsed/Refractory Primary Central Nervous System Lymphoma (PCNSL) and Relapsed/Refractory Primary Testicular Lymphoma (PTL)

NCT02857426

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +5 more
Locations
  • University of Alabama at Birmingham Birmingham, Alabama, United States
  • City Of Hope Medical Center Duarte, California, United States
  • Mayo Clinic Jacksonville Jacksonville, Florida, United States
  • H. Lee Moffitt Cancer Center & Research Inst, Inc Tampa, Florida, United States
View all 50 locations
View Trial Details

Related conditions